| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8281480 | Journal of the Neurological Sciences | 2012 | 4 Pages |
Abstract
Our findings suggest dysregulation of Melatonin secretion in MS, which may be influenced by IFN-β treatment. The results call for further characterization of the role of neuro-hormones such as melatonin in MS, and their cross-regulation with immune-mediators.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Lena Melamud, Daniel Golan, Rafael Luboshitzky, Idit Lavi, Ariel Miller,